InvestSMART

Atomos Limited (ASX:AMS)

ALERT: Price-sensitive ASX Announcement for AMS
Current share price for AMS : $0.011 -0.013 (-54.35%)+
Announcement
Release
30 Apr 2026 2:19PM
Price at Release
$0.023
Full Release
download
Summary
Atomos Limited's Q3 FY26 results showcased a net operating cash inflow of $0.8 million on cash receipts of $10.2 million, marking a third consecutive positive EBITDA quarter despite a slight sales decline to $6.6 million. The company executed a new $10 million CBA Business Finance Facility, achieving interest cost reductions, and completed the acquisition of Flanders Scientific, expanding its professional reference monitoring capabilities. New products were unveiled at NAB Show 2026, enhancing Atomos's ecosystem. The company maintains $1.4 million in cash reserves, aiming to navigate uncertain trading conditions with a focus on maintaining margin quality and cost discipline.
Key Points
  • Atomos Limited released its Appendix 4C and Quarterly Activities Report for Q3 FY26, highlighting a net operating cash inflow of $0.8 million on cash receipts of $10.2 million.
  • The company reported Q3 FY26 sales of $6.6 million, slightly down by 3% year-over-year, attributed to softer trading conditions.
  • Atomos achieved a positive EBITDA for the third consecutive quarter at $0.1 million, despite lower revenue.
  • A new $10 million CBA Business Finance Facility was executed, reducing annual interest costs by approximately $0.7 million.
  • Atomos completed the acquisition of Flanders Scientific, expanding its product ecosystem into professional reference monitoring.
  • The company unveiled new products at NAB Show 2026, including Sumo PRO 19 and other ecosystem updates.
  • Cash and cash equivalents at the end of the quarter stood at $1.4 million, supplemented by the new debt facility.
  • Trading visibility for Q4 remains uncertain due to global macroeconomic conditions, but Atomos aims to maintain margin quality and cost discipline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.